2009-10-21 22:48:02 -

Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it plans to report third quarter 2009 financial results after the market closes on Thursday, October 22, 2009.

The Company also plans to host a webcast of a conference call on Thursday, October 22, 2009 at 4:30 pm EDT (1:30 pm PDT). To access the live audio webcast and the subsequent archived audio recording of the presentation, please log onto Dynavax’s website at investors.dynavax.com/newsevents.cfm : .



About Dynavax

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases. The Company's lead product candidate is HEPLISAV TM , a Phase 3 investigational adult hepatitis B vaccine designed to provide more rapid and increased protection with fewer doses than

current licensed vaccines. For more information visit www.dynavax.com : .



Dynavax Technologies CorporationAmy Figueroa, 510-665-7211Investor
Relations and Corporate CommunicationsEmail: afigueroa@dynavax.com : mailto:afigueroa@dynavax.com